Remdesivir Completed Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT05502081	Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients	Anti-SARS-CoV-2 REGN-COV2 (DB15691) Casirivimab (DB15941) Favipiravir (DB12466) Imdevimab (DB15940) Remdesivir (DB14761)